Advanced search
Publication Cover
Drug Delivery Volume 8, 2001 - Issue 1
Submit an article Journal homepage
190
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Liposomal Bleomycin: Increased Therapeutic Activity and Decreased Pulmonary Toxicity in Mice

D Arndt, R. Zeisig, D. Bechtel, I. Fichtner Max Delbrück Center for Molecular Medicine, Berlin, Germany; University of Cologne, Cologne, Germany; Max Delbru¨ck Center for Molecular Medicine, Berlin, Germany
Pages 1-7 | Published online: 29 Sep 2008

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Martyna Janicka & Jerzy Gubernator. (2017) Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy. Expert Opinion on Drug Delivery 14:9, pages 1059-1075.
Read now
Tao Chen, Deirdre Mcintosh, Yuehua He, Jungsoo Kim, David A. Tirrell, Peter Scherrer, David B. Fenske, Ammen P. Sandhu & Pieter R. Cullis. (2004) Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents. Molecular Membrane Biology 21:6, pages 385-393.
Read now

Articles from other publishers (15)

Mohsen Chiani, Kayhan Azadmanesh, Mohammad Ali Shokrgozar, Mohammad Reza Mehrabi, Azim Akbarzadeh & Dariush Norouzian. (2017) Enhanced antitumor effect of targeted nanoliposomal bleomycin. Chemical Biology & Drug Design 90:5, pages 953-961.
Crossref
Mohsen Chiani, Mohammad Ali Shokrgozar, Kayhan Azadmanesh, Dariush Norouzian, Mohammad Reza Mehrabi, Aazam Najmafshar & Azim Akbarzadeh. (2017) Preparation, characterization, and in vitro evaluation of bleomycin-containing nanoliposomes. Chemical Biology & Drug Design 89:4, pages 492-497.
Crossref
Alexander Koshkaryev, Aleksandr Piroyan & Vladimir P. Torchilin. (2013) Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Cancer Letters 334:2, pages 293-301.
Crossref
N. V. Shatskaya, A. S. Levina, M. N. Repkova, S. I. Baiborodin, N. V. Shikina, Z. R. Ismagilov & V. F. Zarytova. (2013) Delivery of bleomycin A5 into cells using TiO2 nanoparticles to enhance the degradation of intracellular DNA. Nanotechnologies in Russia 8:3-4, pages 277-282.
Crossref
Dindial Ramotar & Mustapha Aouida. 2013. Advances in DNA Repair in Cancer Therapy. Advances in DNA Repair in Cancer Therapy 187 209 .
Tilen Koklic & Janez trancar. (2012) Lysolipid containing liposomes for transendothelial drug delivery. BMC Research Notes 5:1.
Crossref
William M. GwinnMayanga C. KapitaPing M. WangMark F. Cesta & William J. MartinIIII. (2011) Synthetic liposomes are protective from bleomycin-induced lung toxicity. American Journal of Physiology-Lung Cellular and Molecular Physiology 301:2, pages L207-L217.
Crossref
Abdullah H. Alomrani, Gamal M. El Maghraby, Fars K. Alanazi, Mai A. Al-Mohanna, Ayodele A. Alaiya & Ibrahim A. Alsarra. (2011) Liposomes for enhanced cytotoxic activity of bleomycin. Drug Development Research 72:3, pages 265-273.
Crossref
Monika Zochowska, Agnieszka Paca, Guy Schoehn, Jean-Pierre Andrieu, Jadwiga Chroboczek, Bernard Dublet & Ewa Szolajska. (2009) Adenovirus Dodecahedron, as a Drug Delivery Vector. PLoS ONE 4:5, pages e5569.
Crossref
Chun-Chao Chang, Der-Zen Liu, Shyr-Yi Lin, Hong-Jen Liang, Wen-Chi Hou, Wei-Jan Huang, Chih-Hsiang Chang, Feng-Ming Ho & Yu-Chih Liang. (2008) Liposome encapsulation reduces cantharidin toxicity. Food and Chemical Toxicology 46:9, pages 3116-3121.
Crossref
Aristarchos Papagiannaros, Sophia Hatziantoniou, Konstantinos Dimas, George Th. Papaioannou & Costas Demetzos. (2006) A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines. Biomedicine & Pharmacotherapy 60:1, pages 36-42.
Crossref
J. Lee White & Marcel E. Durieux. (2005) Clinical Pharmacology of Local Anesthetics. Anesthesiology Clinics of North America 23:1, pages 73-84.
Crossref
Reinhard Zeisig, Anne-Dorthee Teppke, Diana Behrens & Iduna Fichtner. (2004) Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro. Breast Cancer Research and Treatment 87:3, pages 245-254.
Crossref
Reiner Zeisig, Dominik Rückerl & Iduna Fichtner. (2004) Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo. Anti-Cancer Drugs 15:7, pages 707-714.
Crossref
Linda Mileshkin, Yoland Antill & Danny Rischin. 2004. Gynecologic Cancer. Gynecologic Cancer 605 628 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.